APP and early-onset autosomal dominant Alzheimer disease: Penton-Rol et al. [116] demonstrated, in the animal model, that C-PC can promote significant axonal remyelination, as well as reduce the Amyloid Precursor Protein (APP), a marker protein of Alzheimer’s disease.